ALPMY - Cytokinetics: Multiple Growth Catalysts Ahead In 2020
Today, we will see why Cytokinetics (CYTK) can be an attractive pick in 2020.
Company overview
Cytokinetics is a clinical-stage biotechnology company focused on developing innovative treatment options targeting cardiovascular and neuromuscular diseases caused due to impaired muscle function. The company is targeting indications such as heart failure, HCM (hypertrophic cardiomyopathies), ALS (amyotrophic lateral sclerosis), and SMA (spinal muscular atrophy). Cytokinetics is focusing on crucial proteins such as myosins and troponins within muscle cells which regulate its ability to contract and relax. Using this principle, the company is developing cardiac muscle activators and